login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
TRANSCODE THERAPEUTICS INC (RNAZ) Stock News
NASDAQ:RNAZ - Nasdaq -
US89357L4023
-
Common Stock
- Currency: USD
11
-0.15 (-1.35%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RNAZ Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Chartmill
- Mentions:
OPEN
LMFA
CLSD
REPL
...
Which stocks are experiencing notable movement on Wednesday?
8 days ago - By: Chartmill
- Mentions:
GPRO
VICR
OPEN
FI
...
These stocks are gapping in today's session
8 days ago - By: Benzinga
- Mentions:
TLX
GDTC
CLSD
IOVA
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
8 days ago - By: Chartmill
- Mentions:
GPRO
VICR
TZOO
TXN
...
These stocks that are showing activity before the opening bell on Wednesday.
8 days ago - By: Benzinga
- Mentions:
TLX
MEIP
HCTI
ICU
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
3 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported
3 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Effective Date for 1-for-28 Reverse Stock Split
3 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics Announces 1-for-28 Reverse Stock Split
3 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics Reports Further Progress on Phase 1a Clinical Trial with No Dose Limiting Toxicities Reported in Patients with Metastatic Cancer
3 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting
3 months ago - By: Zacks Investment Research
All You Need to Know About TransCode Therapeutics (RNAZ) Rating Upgrade to Buy
4 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138
4 months ago - By: TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering
Please enable JavaScript to continue using this application.